Literature DB >> 25060580

Assembly and localization of Toll-like receptor signalling complexes.

Nicholas J Gay1, Martyn F Symmons1, Monique Gangloff1, Clare E Bryant2.   

Abstract

Signal transduction by the Toll-like receptors (TLRs) is central to host defence against many pathogenic microorganisms and also underlies a large burden of human disease. Thus, the mechanisms and regulation of signalling by TLRs are of considerable interest. In this Review, we discuss the molecular basis for the recognition of pathogen-associated molecular patterns, the nature of the protein complexes that mediate signalling, and the way in which signals are regulated and integrated at the level of allosteric assembly, post-translational modification and subcellular trafficking of the components of the signalling complexes. These fundamental molecular mechanisms determine whether the signalling output leads to a protective immune response or to serious pathologies such as sepsis. A detailed understanding of these processes at the molecular level provides a rational framework for the development of new drugs that can specifically target pathological rather than protective signalling in inflammatory and autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25060580     DOI: 10.1038/nri3713

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  110 in total

1.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

2.  Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.

Authors:  Umeharu Ohto; Koichi Fukase; Kensuke Miyake; Yoshinori Satow
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

3.  An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4.

Authors:  Precious G Motshwene; Martin C Moncrieffe; J Günter Grossmann; Cheng Kao; Murali Ayaluru; Alan M Sandercock; Carol V Robinson; Eicke Latz; Nicholas J Gay
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

4.  Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.

Authors:  Takahiro Yamamoto; Naotaka Tsutsumi; Hidehito Tochio; Hidenori Ohnishi; Kazuo Kubota; Zenichiro Kato; Masahiro Shirakawa; Naomi Kondo
Journal:  Mol Immunol       Date:  2013-12-05       Impact factor: 4.407

5.  Targeting TLR4 signaling by TLR4 Toll/IL-1 receptor domain-derived decoy peptides: identification of the TLR4 Toll/IL-1 receptor domain dimerization interface.

Authors:  Vladimir Y Toshchakov; Henryk Szmacinski; Leah A Couture; Joseph R Lakowicz; Stefanie N Vogel
Journal:  J Immunol       Date:  2011-03-14       Impact factor: 5.422

6.  Synergy between TLR2 and TLR4: a safety mechanism.

Authors:  E Beutler; T Gelbart; C West
Journal:  Blood Cells Mol Dis       Date:  2001 Jul-Aug       Impact factor: 3.039

7.  Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.

Authors:  Jin Gohda; Takayuki Matsumura; Jun-ichiro Inoue
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

8.  Structural insight into the mechanism of activation of the Toll receptor by the dimeric ligand Spätzle.

Authors:  Monique Gangloff; Ayaluru Murali; Jin Xiong; Christopher J Arnot; Alexander N Weber; Alan M Sandercock; Carol V Robinson; Robert Sarisky; Andreas Holzenburg; Cheng Kao; Nicholas J Gay
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

9.  Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

Authors:  Mark Rutz; Jochen Metzger; Tanja Gellert; Peter Luppa; Grayson B Lipford; Hermann Wagner; Stefan Bauer
Journal:  Eur J Immunol       Date:  2004-09       Impact factor: 5.532

10.  Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.

Authors:  Sarah E Ewald; Alex Engel; Jiyoun Lee; Miqi Wang; Matthew Bogyo; Gregory M Barton
Journal:  J Exp Med       Date:  2011-03-14       Impact factor: 14.307

View more
  267 in total

1.  Systematic analysis of immunodeficiency.

Authors:  David F Tough
Journal:  Nat Immunol       Date:  2014-12       Impact factor: 25.606

Review 2.  Microbiota and host immune responses: a love-hate relationship.

Authors:  Sarah Tomkovich; Christian Jobin
Journal:  Immunology       Date:  2015-11-02       Impact factor: 7.397

Review 3.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

4.  Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3).

Authors:  Kirsten J Koymans; Louris J Feitsma; T Harma C Brondijk; Piet C Aerts; Eddie Lukkien; Philip Lössl; Kok P M van Kessel; Carla J C de Haas; Jos A G van Strijp; Eric G Huizinga
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

5.  Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

Authors:  Christian Grommes; Alessandro Pastore; Nicolaos Palaskas; Sarah S Tang; Carl Campos; Derrek Schartz; Paolo Codega; Donna Nichol; Owen Clark; Wan-Ying Hsieh; Dan Rohle; Marc Rosenblum; Agnes Viale; Viviane S Tabar; Cameron W Brennan; Igor T Gavrilovic; Thomas J Kaley; Craig P Nolan; Antonio Omuro; Elena Pentsova; Alissa A Thomas; Elina Tsyvkin; Ariela Noy; M Lia Palomba; Paul Hamlin; Craig S Sauter; Craig H Moskowitz; Julia Wolfe; Ahmet Dogan; Minhee Won; Jon Glass; Scott Peak; Enrico C Lallana; Vaios Hatzoglou; Anne S Reiner; Philip H Gutin; Jason T Huse; Katherine S Panageas; Thomas G Graeber; Nikolaus Schultz; Lisa M DeAngelis; Ingo K Mellinghoff
Journal:  Cancer Discov       Date:  2017-06-15       Impact factor: 39.397

6.  Tril targets Smad7 for degradation to allow hematopoietic specification in Xenopus embryos.

Authors:  Yangsook Song Green; Sunjong Kwon; Mizuho S Mimoto; Yuanyuan Xie; Jan L Christian
Journal:  Development       Date:  2016-09-15       Impact factor: 6.868

7.  Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis.

Authors:  Fabio Alessandro Facchini; Davide Di Fusco; Simona Barresi; Andrea Luraghi; Alberto Minotti; Francesca Granucci; Giovanni Monteleone; Francesco Peri; Ivan Monteleone
Journal:  Eur J Clin Pharmacol       Date:  2020-01-25       Impact factor: 2.953

8.  Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection.

Authors:  Charlotte Odendall; Andrew A Voak; Jonathan C Kagan
Journal:  J Immunol       Date:  2017-09-27       Impact factor: 5.422

Review 9.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

10.  Duplicated TLR5 of zebrafish functions as a heterodimeric receptor.

Authors:  Carlos G P Voogdt; Jaap A Wagenaar; Jos P M van Putten
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.